Recruiting
Phase 3

RZ358

Sponsor:

Rezolute

Code:

NCT06208215

Conditions

Congenital Hyperinsulinism

Eligibility Criteria

Sex: All

Age: 3 - 45

Healthy Volunteers: Not accepted

Interventions

RZ358 (5 mg/kg) + SOC (Standard-of-Care) or Placebo + SOC

RZ358 (10 mg/kg) or Placebo + SOC

RZ358 (5-10 mg/kg) + SOC

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Rezolute on 2025-03-06.